Anti-Human HLA-DRA Antibody
Anti-Human HLA-DRA Antibody with collaborator-tested evidence for IHC. Read more ›
["IHC"]Product Description
HLA-DRA is the stated target for this antibody product. The listing uses collaborator-supplied technical data from Elabscience and is structured for research-use-only antibody selection through ABMIUM.
Product profile: reactivity: Human; host: Rabbit; clonality: Polyclonal; isotype: IgG; available conjugation options: Unconjugated.
Application evidence: Elabscience lists this product for IHC. In the ABMIUM matrix, these listed applications are marked C to show collaborator-tested ABMIUM Verified evidence. Applications not listed in the supplied data remain marked N.
Technical notes: immunogen: Synthetic peptide of human HLA-DRA; purification: Antigen affinity purification; concentration: 0.9 mg/mL.
Database references: UniProt: P01903 | NCBI Gene: 3122.
Research Use Only.
Key Facts
| Target | HLA-DRA |
| Also known as | DR alpha chain, DR alpha chain precursor, DRA, DRB1, DRB4, HLA , HLA DR1B, HLA DR3B, HLA DRA, HLA DRA1, HLA DRB1, HLA DRB3, HLA DRB4, HLA class II histocompatibility antigen, HLA class II histocompatibility antigen DR alpha chain, Histocompatibility antigen HLA DR alpha |
| Concentration | 0.9 mg/mL |
| Species reactivity | Human |
| Shelf life | 12 months from shipping dates |
| Research area | Cancer, Immunology |
| WB | IHC-P | IHC-FR | IF/ICC | FLOW CYT | IP | CHIP | IHC | |
|---|---|---|---|---|---|---|---|---|
| Human |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.